Mirtazapine Tablet
Product Images NDC 63629-2368

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 63629-2368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)

FDA Label Image

Label (Lbl636292368)

Label (Lbl636292368)
The text is a description of a medication called NILD. It contains Mirtazapine, USP 30 mg and comes in the form of tablets. It is recommended to keep the medication away from children and store it in a tightly sealed container at a temperature of 20° to 25°C (68° to 77°F) as per USP Controlled Room Temperature. This medication appears to require a prescription (Rx only). The NDC (National Drug Code) for the Mirtazapine Tablets, USP is 63629-2368-1.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.